News About: Pharm. Industry
KGC signs ginseng export deal
Korea Ginseng Corporation (KTC) has signed a contract with a Saudi Arabian Company to export its red ginseng extract.
The deal with AL MUTAWA group in the scale of $20 million was made available after acquiring GMP...
Hanmi exports combo drug to overseas markets
Local drug maker Hanmi Pharm said on July 20 that it will export its independently developed incrementally modified drug (IMD) to overseas markets through a multinational pharmaceutical company.
The company said on...
KFDA to ameliorate biosimilar related rules
The Korea Food and Drug Administration has recently unveiled its plan to effectively implement the recently updated biosimilar regulations as part of efforts to promote local biosimilar business.
The drug agency sa...
Green Cross likely to supply 12 million doses of flu A vaccines
Although health authorities downplay the worries about the H1N1 flu, stressing that the virus presently remains in a mild form, the continuing spread of influenza A, still in the early stages of the outbreak, has crit...
Macrogen to sequence Asian gene map
Macrogen Inc. Chairman Suh Jung-sun said on July 20 that the company will conduct the sequencing of the Asian gene map in collaboration with the government and private organizations.
He added that the job will be c...
40% of 10 Koreans suffer abdominal pain
About 40 percent of 10 Korean people are said to experience abdominal disorders (pain, discomfort or spasm) once a year, according to a recent survey of 1,000 adults, conducted by Boehringer Ingelheim Korea.
53.8 p...
Dong-A’s Stillen enjoys robust sales in first half
Dong-A Pharm says its Stillen garnered 40 billion won in the domestic ulceration drug market for the January-June period of this year, up a whopping 145 percent compared with the same period a year earlier.
The mar...
Concerns growing over domestic market entry of leading generic companies
Korean pharmaceutical firms are jittery over possible entry of leading foreign companies, such as Cipla Limited and Teva.
Cipla Limited is looking to seek Korean partners to market their hundreds of generic medicat...
Hanmi in tie-up with Samsung Electronics
Hanmi Pharm said on July 20 that it signed a Memorandum of Understanding (MOU) with Samsung Electronics, the world's No. 2 maker of chips and handsets, to exclusively market a table-type ionizer purifier “Virus Doctor...
169 clinical trials approved in first half
The Korea Food and Drug Administration said it approved a total of 169 clinical trials in the first half of this year.
The number of clinical trials conducted by domestic pharmaceutical firms, such as Boryung Pharm...
